An evaluation of potential mechanism-based inactivation of human drug metabolizing cytochromes P450 by monoamine oxidase inhibitors, including isoniazid

AIMS: To characterize potential mechanism-based inactivation (MBI) of major human drug-metabolizing cytochromes P450 (CYP) by monoamine oxidase (MAO) inhibitors, including the antitubercular drug isoniazid. METHODS: Human liver microsomal CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A activities were inv...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Polasek, Thomas M, Elliot, David J, Somogyi, Andrew A, Gillam, Elizabeth M J, Lewis, Benjamin C, Miners, John O
Médium: Artigo
Jazyk:Inglês
Vydáno: Blackwell Science Inc 2006
Témata:
Drug Metabolism
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1885050/
https://ncbi.nlm.nih.gov/pubmed/16669850
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2006.02627.x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky